Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Timothy K Erick

2PUBLICATIONS
14CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Feb 05, 2025
A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast Cancer.

Shom Goel, Bojana Jovanović, Xiangying Chu

|Nov 07, 2019
Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice.

Jennifer M Curry, Dahlia M Besmer, Timothy K Erick

Pageof 1

Frequent Collaborators

1 joint publications

Jacob W Ferrier

1 joint publications

Shom Goel

1 joint publications

Bojana Jovanović

1 joint publications

Xiangying Chu

1 joint publications

Melissa Hughes

1 joint publications

Douglas Russo

1 joint publications

Molly DiLullo

1 joint publications

Eileen Wrabel

1 joint publications

Rinath Jeselsohn

1 joint publications

Nancy U Lin

Frequent Collaborators

1 joint publications

Jacob W Ferrier

1 joint publications

Shom Goel

1 joint publications

Bojana Jovanović

1 joint publications

Xiangying Chu

Top Related Videos

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on : Mar 20, 2020

17.4K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

21.6K
See more related videos

Top Related Videos

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on : Mar 20, 2020

17.4K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

21.6K
See more related videos